Idaho-based entrepreneur and sales professional Steve Verschoor graduated with a BS in electrical engineering from the Keller School of Management in Phoenix, Arizona. Steve Verschoor is a co-founder of Molecular Testing Labs, a provider of affordable innovative medical testing solutions for multiple diseases including COVID-19, HPV and other STIs.
In the wake of the isolation practices put into effect to respond to the COVID-19 pandemic in 2020, Molecular Testing Labs was one of the laboratories that adopted HIV testing through home specimen collection kits. This was particularly vital for patients receiving pre-exposure prophylaxis services, or PrEP. PrEP is a preventive treatment for HIV and involves taking daily pills either to reduce the risk of contracting the virus, or to treat contraction in the early stages in combination with other medicines.
To ensure that people could continue treatment for HIV, the Center for Disease Control and Prevention suggested two options for quarterly HIV testing: an oral swab test and a home specimen collection kit. Of the two, the home specimen kit is more accurate at providing results for patients undergoing PrEP. Molecular Testing Labs has validated protocols for testing home-collected samples, which allows patients to get themselves checked without risking the chances of contracting the COVID-19 infection by leaving their homes. The home specimen kits, which contain supplies to collect blood samples for analysis, are mailed to each patient’s home. Once the patients have collected samples themselves, they mail the kits back to the lab for analysis. The results of the analysis are then to the patients’ clinicians for necessary action. Importantly, the patient can feel confident in the lab sample collection and testing as both have been approved and recommended by the CDC as outlined in the following letter ( https://www.cdc.gov/hiv/policies/dear-colleague/dcl/051520.html ).
Steve Verschoor 